title: Neurotensin elevates hematocrit and plasma levels of the leukotrienes, LTB4, LTC4, LTD4 and LTE4, in anesthetized rats.
abstract: The IV injection of neurotensin (NT) into anesthetized rats produced a marked increase in hematocrit, labored breathing and peripheral blood stasis with cyanosis. This effect could also be produced by the NT-related peptides, neuromedin-N and xenopsin; however, it was not observed when nine other biologically active peptides, including bradykinin and substance P, were tested. Associated with these responses were increases in the plasma levels of histamine (measured radioenzymatically) and the leukotrienes, LTB4, LTC4, LTD4, and LTE4 (measured by RIA and HPLC). The increment in hematocrit after varying doses of NT correlated to the increase in plasma levels of LTC4. Histamine and LTC4 were both capable of elevating hematocrit when given IV; however, LTC4 was approximately 1000 times more potent than histamine and active doses of histamine elevated LTC4 levels. Furthermore, the effects of NT on plasma LTC4 and hematocrit were reduced by pretreating animals with antagonists to histamine and serotonin. Pretreatment with the specific mast cell degranulating agent, compound 48/80, also blocked NT's ability to elevate plasma levels of histamine, LTB4 and LTC4 and prevented the increased hematocrit and cyanosis. These results indicate that NT-related peptides are very potent and specific stimulators of leukotriene release and that this action is mediated by mast cells and associated with loss of plasma volume and blood stasis. A working hypothesis is that histamine, released from mast cells in response to NT, stimulates LTC4 production by other cells.
authors.affiliation: Department of Physiology, University of Massachusetts Medical School, Worcester 01650.
authors.forename: R E
authors.initials: RE
authors.lastname: Carraway
authors.forename: D E
authors.initials: DE
authors.lastname: Cochrane
authors.forename: R
authors.initials: R
authors.lastname: Salmonsen
authors.forename: K
authors.initials: K
authors.lastname: Muraki
authors.forename: W
authors.initials: W
authors.lastname: Boucher
mesh_terms: D000768:Anesthesia, General; D000818:Animals; D004305:Dose-Response Relationship, Drug; D006400:Hematocrit; D006632:Histamine / Q000097:blood; D006633:Histamine Antagonists / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D007975:Leukotriene B4 / Q000097:blood; D009496:Neurotensin / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D013189:SRS-A / Q000097:blood* / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D013997:Time Factors
chemical_list: D006633:Histamine Antagonists; D006728:Hormones; D010455:Peptides; D011453:Prostaglandins; D013189:SRS-A; D012702:Serotonin Antagonists; D007975:Leukotriene B4; D009496:Neurotensin; D006632:Histamine